WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion
Shares of Global Blood Therapeutics Inc. (GBT) jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc. (PFE) is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company's stock is up 79.6% this year, while the broader S&P 500 is down 12.8%.
(END) Dow Jones Newswires
August 05, 2022 11:58 ET (15:58 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.